PRECIPIO, INC. Accounts Receivable, before Allowance for Credit Loss
PRECIPIO, INC. (PRPO) had Accounts Receivable, before Allowance for Credit Loss of $3.57 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Accounts Receivable, after Allowance for Credit Loss
us-gaap:AccountsReceivableGross · last filed 2026-08-14
- 2026-06-30: Accounts Receivable, before Allowance for Credit Loss $3.57M.
- 2026-03-31: Accounts Receivable, before Allowance for Credit Loss $3.28M.
- 2025-12-31: Accounts Receivable, before Allowance for Credit Loss $3.03M.
- 2025-09-30: Accounts Receivable, before Allowance for Credit Loss $3.01M.
| Period end | Accounts Receivable, before Allowance for Credit Loss |
|---|---|
| 2026-06-30 | $3.57M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $3.28M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $3.03M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $3.01M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $2.42M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $1.93M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $1.79M 10-K · filed 2026-03-30 |
| 2024-09-30 | $3.78M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $3.79M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $3.56M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $3.87M 10-K · filed 2025-03-27 |
| 2023-09-30 | $4.01M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $3.36M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $3.22M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $3.39M 10-K · filed 2024-03-29 |
| 2022-09-30 | $3.15M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $3.24M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $3.18M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $3.18M 10-K · filed 2023-03-30 |
| 2021-09-30 | $1.87M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $1.85M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $4.93M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $4.89M 10-K · filed 2022-03-30 |
| 2020-09-30 | $4.79M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $4.63M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $3.83M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $3.25M 10-K · filed 2021-03-29 |
| 2019-09-30 | $3.13M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $3.05M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $2.71M 10-Q · filed 2019-05-16 |
| 2018-12-31 | $2.40M 10-K · filed 2020-03-27 |
| 2018-09-30 | $2.18M 10-Q · filed 2018-11-19 |
| 2018-06-30 | $2.10M 10-Q · filed 2018-08-16 |
| 2018-03-31 | $1.76M 10-Q · filed 2018-05-21 |
| 2017-12-31 | $1.86M 10-K · filed 2019-04-16 |
| 2016-12-31 | $1.20M 10-K · filed 2018-04-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |